As the director of the NYU Langone Lung Cancer Biomarker Program, I am dedicated to advancing the early detection of lung cancer through innovative research and compassionate care. My role allows me to combine my passion for scientific discovery with my commitment to improving patient outcomes, particularly for those at high risk for lung cancer.

I specialize in lung cancer, focusing on identifying and validating biomarkers that can detect the disease at its earliest stages. With extensive experience in bronchoscopy and a deep interest in the lung microbiome, I bring a comprehensive approach to diagnosing and managing lung conditions. My years of specialized training and practice have equipped me with the expertise necessary to provide top-tier care for my patients.